Recipient of the Global Health Award in recognition of outstanding contributions to international healthcare advancement and regenerative medicine innovation.
"Key Technology Innovation and Clinical Application of Allogeneic Mesenchymal Stem Cells for Refractory Lupus Erythematosus", one of China's highest honours in biomedical innovation.
AABB, the American Association of Blood Banks, invited Beike to contribute to developing the world's first international standard for Mesenchymal Stem Cells. A recognition of 23C's global leadership in cell quality.
China's top leadership has visited 23C's scientific parent Beike Biotech on multiple occasions, a rare distinction that speaks to the national and global significance of our work in regenerative medicine.
Prof. Sean Hu Xiang briefed General Secretary Hu on the international status of stem cell research and China's future in this field.
"The stem cell research carried out by Beike is the forefront of biotechnology, the most promising field beyond developed countries in the West."
Official visit to Beike's research and manufacturing facility, one of China's most senior government figures in energy, telecommunications, and transportation policy.
Visit from one of China's top reformist leaders, a member of the Politburo Standing Committee under Premier Li Keqiang's government.
Official visit from former party secretary of Guangdong and chairman of the Central Politburo, one of China's most senior political figures.
Visit and recognition reported in Xinhua, China Press, and local China news, a symbol of 23C's international reach and diplomatic standing.
Discover how 23C's credentials can support your recovery journey.
Begin Your Enquiry